Skip to main content
. 2022 Dec 22;37(3):529–538. doi: 10.1038/s41375-022-01799-4

Fig. 1. Classification of B-other-ALL cohort according to technique.

Fig. 1

Sankey plot showing the number of patients tested by each technique and those classified into genomic subtypes of B-other-ALL, as defined in Table 1. *Cases tested by FISH and/or MLPA, not all cases by all kits and probes. **Excludes 9 patients with other subtype defining abnormalities. WGS Whole genome sequencing, t-NGS Targeted next generation sequencing, FISH Fluorescence in situ hybridisation, MLPA Multiplex Ligation-dependent Probe Amplification.